Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Global Veterinary Reference Laboratory Market: Companion Animal Oncology Testing and Diagnostic Consolidation to Drive Market Growth

The global Veterinary Reference Lab market was valued at USD 5.2 billion in 2025 and is projected to reach USD 9.24 billion by 2035, expanding at a CAGR of 6.6%. Veterinary reference laboratories provide advanced diagnostic testing — histopathology, cytology, microbiology, molecular diagnostics, specialised chemistry panels, serology, and oncology panels — that complements in-clinic POC platforms. The market is consolidating around two dominant global networks: IDEXX Laboratories (approximately 80 reference laboratories) and Mars-owned Antech Diagnostics, whose scale creates geographic coverage, turnaround time, and test menu breadth that regional laboratories cannot match.

The IDEXX Cancer Dx Panel — launched in 2025 as a simple blood test screening dogs for lymphoma — is the most commercially significant new reference laboratory test in the companion animal market in years, creating an oncology screening category from a high-prevalence condition that generates follow-up diagnostics, specialist referral, and treatment revenue. Zoetis’s November 2025 acquisition of Veterinary Pathology Group (VPG) across the UK and Ireland expands the competitive landscape to include pharmaceutical companies vertically integrating into reference laboratory services.

Executive Snapshot

What is the confirmed market size and growth trajectory for the veterinary reference laboratory market?
The market was valued at USD 5.2 billion in 2025 and is projected to grow at a CAGR of 6.6% to USD 9.24 billion by 2035. IDEXX and Antech dominate with approximately 80 and 70-plus global laboratories respectively. Histopathology and cytology are dominant test categories. Molecular diagnostics (PCR, NGS) are fastest-growing. Same-day/next-day turnaround is the competitive requirement. North America is dominant; Asia-Pacific grows fastest.

How does IDEXX’s Cancer Dx Panel create a new revenue category for reference laboratories?
The IDEXX Cancer Dx Panel — detecting circulating lymphoma biomarkers in a routine blood draw — creates a new oncology screening service that practices order at annual wellness visits for dogs above age 7. At USD 150 to USD 300 per panel, high-frequency wellness visit integration generates substantial incremental reference laboratory revenue per practice per year. Mast cell tumour detection in 2026 and international lymphoma launch in H1 2026 build a multi-panel companion animal oncology diagnostic platform.

How does Zoetis’s VPG acquisition change the competitive landscape?
Zoetis’s November 2025 acquisition of Veterinary Pathology Group — a leading UK and Ireland reference laboratory network — marks the entry of the world’s largest animal health pharmaceutical company into the reference laboratory market, creating a vertically integrated competitor offering pharmaceuticals, vaccines, point-of-care diagnostics, and reference laboratory services within a single commercial relationship with veterinary practices.

What test categories are growing fastest in veterinary reference laboratories?
Molecular diagnostics — PCR-based pathogen identification, vector-borne disease panels, and next-generation sequencing for antimicrobial resistance profiling — are growing fastest by revenue growth rate, replacing culture-and-sensitivity microbiology with same-day pathogen identification with resistance gene characterisation. Oncology panels (cytology, flow cytometry, cancer biomarkers) are the fastest-growing companion animal test category by volume.

How does the reference laboratory market serve biomedical research customers?
IDEXX’s reference laboratory network provides health monitoring and diagnostic testing to biomedical research institutions in North America, Europe, and Asia — supporting sentinel animal health monitoring, colony surveillance, and research study diagnostic support. This research customer segment provides revenue independent of companion animal clinical practice volume and grows with biomedical research funding cycles.

How do same-day and next-day turnaround requirements sustain competitive concentration?
Veterinary practices require diagnostic results within 24 hours for most clinical applications. IDEXX’s approximately 80-laboratory geographic distribution enables same-day courier pick-up and overnight processing across the U.S., Europe, Canada, and other major markets — creating a logistical infrastructure barrier that regional single-laboratory competitors cannot replicate.

Request Sample
Speak with an Analyst
Download TOC

Market Dynamics: Global Veterinary Reference Laboratory Market

  • IDEXX Cancer Dx Panel creating companion animal oncology screening as a mainstream annual wellness testing category. Canine lymphoma blood test integrating into annual wellness visits creating recurring oncology screening revenue above episodic disease investigation testing.
  • Zoetis VPG acquisition creating pharmaceutical-laboratory vertical integration competitive model above pure-play reference laboratory networks. Zoetis entering reference laboratory market through VPG UK/Ireland acquisition creates vertically integrated competitor combining pharmaceuticals, POC diagnostics, and reference laboratory services.
  • Molecular diagnostics PCR growing fastest from same-day pathogen identification replacing culture-and-sensitivity methods. PCR and molecular diagnostic adoption growing fastest as same-day pathogen ID with resistance profiling replaces 48-72 hour culture-based microbiology for veterinary infectious disease diagnosis.
  • Antech and IDEXX consolidation pressure reducing independent regional reference laboratory market share over time. IDEXX and Antech geographic expansion and test menu breadth creating competitive pressure that reduces independent regional reference laboratory market share over time.
  • Asia-Pacific reference laboratory market growing from rising companion animal ownership and veterinary diagnostic standard adoption. China, Japan, South Korea, and Australia reference laboratory markets growing from rising companion animal ownership and increasing diagnostic testing standards.
  • IDEXX telemedicine digital pathology enabling remote specialist consultation alongside reference laboratory services. IDEXX telemedicine radiology and specialist consultation connecting reference laboratory specialists to primary care veterinarians — creating diagnostic consultation value above test result alone.

Market Segmentation: Global Veterinary Reference Laboratory Market

By Application
  • Clinical Pathology
  • Bacteriology
  • Virology
  • Parasitology
  • Productivity Testing
  • Pregnancy Testing
  • Toxicology Testing
  • Genetic Testing
  • Food Safety & Zoonotic Disease Testing
  • Other Applications
By Sample Type
  • Blood
  • Urine
  • Feces
  • Tissue & Biopsy Samples
  • Serum & Plasma
  • Swab Samples
  • Milk
  • Other Sample Types
By Technology
  • Immunoassays
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Clinical Chemistry Analyzers
  • Hematology Analyzers
  • Flow Cytometry
  • Mass Spectrometry
  • Other Diagnostic Technologies
By End User
  • Veterinary Hospitals & Clinics
  • Point-of-Care (POC) / In-House Testing Facilities
  • Veterinary Research Institutes & Universities
  • Animal Diagnostic Laboratories
  • Livestock Farms
  • Government & Public Health Agencies
  • Pharmaceutical & Biotechnology Companies
  • Other End Users
By Service Type
  • Clinical Chemistry
    • Blood Chemistry Testing
    • Liver Function Tests
    • Kidney Function Tests
    • Electrolyte Analysis
    • Endocrinology Testing
    • Other Clinical Chemistry Tests
  • Immunodiagnostics
    • ELISA
    • Lateral Flow Assays
    • Allergen-Specific Immunodiagnostic Tests
    • Immunofluorescence Assays (IFA)
    • Chemiluminescence Immunoassays (CLIA)
    • Other Immunodiagnostic Services
  • Molecular Diagnostics
    • PCR Tests
    • Real-Time PCR (qPCR)
    • Microarrays
    • Nucleic Acid Sequencing (NGS)
    • Isothermal Amplification
    • Other Molecular Diagnostic Services
  • Hematology
    • Complete Blood Count (CBC)
    • Coagulation Testing
    • Blood Smear Analysis
    • Other Hematology Tests
  • Urinalysis
    • Routine Urinalysis
    • Urine Chemistry
    • Urine Sediment Examination
    • Other Urinalysis Services
  • Histopathology & Cytology
    • Tissue Histopathology
    • Fine Needle Aspiration Cytology (FNAC)
    • Biopsy Analysis
    • Other Histopathology & Cytology Services
  • Microbiology
    • Bacterial Culture & Sensitivity Testing
    • Fungal Testing
    • Antimicrobial Susceptibility Testing
    • Mycology
    • Other Microbiology Services
  • Other Services
    • Toxicology Testing
    • Genetic Testing
    • Allergy Testing
    • Nutritional Analysis
    • Parasitology
    • Reproductive Testing
    • Other Specialized Laboratory Services
By End User
  • Biopharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Contract Development & Manufacturing Organizations (CDMOs/CMOs)
  • Academic & Research Institutions
  • Food & Beverage Companies
  • Industrial Biotechnology Companies
  • Government & Public Research Laboratories
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Global Veterinary Reference Laboratory Market

  1. IDEXX Cancer Dx Panel creating companion animal oncology screening as a mainstream annual wellness testing category with specialist referral pull-through. Companion animal oncology screening creating new recurring reference laboratory revenue from high-frequency annual wellness visit integration — sustaining above-market reference laboratory growth.
  2. Pet humanisation creating structurally non-discretionary companion animal healthcare spending. Pet humanisation elevating companion animal spending to human medicine equivalence creates non-discretionary investment growing with pet ownership.
  3. One Health framework sustaining government investment in animal health independent of commercial cycles. One Health policy funding zoonotic surveillance, AMR stewardship, and food safety — supporting animal health market growth beyond commercial cycles.
  4. Global protein demand driving farm animal production intensification. Emerging market protein consumption growth requiring intensification that creates proportionate farm animal health product demand.
  5. mAb therapeutics (Cytopoint, Librela, Solensia) creating recurring monthly revenue above single-purchase pharmaceutical cycles. Monthly-dosed mAb therapeutics generating recurring clinical revenue that compounds market growth above conventional product replacement.
  6. Asia-Pacific simultaneous pet ownership expansion and livestock intensification creating fastest-growing regional demand. Asia-Pacific growing fastest from dual companion animal and livestock market development driven by economic growth and urbanisation.

Regional Outlook: Global Veterinary Reference Laboratory Market

  • North America: Dominant market anchored by Zoetis’s approximately 18% global market share and USD 9.5 billion 2025 revenue, and IDEXX’s approximately 80-laboratory global reference network.
  • Europe: Significant established market where Boehringer Ingelheim Animal Health and Virbac operate under EU 2019/6 — the world’s most stringent antimicrobial stewardship regulation.
  • Asia-Pacific: Fastest-growing regional market from China’s pet ownership boom, India’s livestock intensification, and Southeast Asia’s growing veterinary adoption.

Competitive Landscape: Global Veterinary Reference Laboratory Market

Key Players: Zoetis Inc. (NYSE: ZTS), Elanco Animal Health (NYSE: ELAN), Boehringer Ingelheim Animal Health, Merck Animal Health, IDEXX Laboratories (NASDAQ: IDXX), Virbac, Vétoquinol, Ceva Santé Animale, Antech Diagnostics (Mars), Dechra Pharmaceuticals, Phibro Animal Health, and Norbrook Laboratories

Recent Developments

  • IDEXX Laboratories’ FY2025 Annual Report filed with the SEC confirmed IDEXX’s commercial reference laboratory network of approximately 80 laboratories worldwide — with same-day or next-day turnaround across the U.S., Europe, Canada, Australia, Japan, New Zealand, South Africa and South Korea — and the 2025 launch of the IDEXX Cancer Dx Panel (canine lymphoma blood test), with mast cell tumour detection in 2026 and international lymphoma launch in H1 2026.
  • Zoetis’ FY2025 Annual Report filed with the SEC confirmed Zoetis’s November 2025 acquisition of Veterinary Pathology Group (VPG) — a leading veterinary diagnostic laboratory group with multiple locations across the UK and Ireland — expanding Zoetis’s diagnostics portfolio into the reference laboratory market and creating a vertically integrated competitor alongside IDEXX and Antech.
  • IDEXX Laboratories’ FY2025 Annual Report filed with the SEC confirmed IDEXX’s cancer screening services — aiding in diagnosis, assisting in therapy selection, and supporting therapy management and monitoring — and its diagnostic laboratory services to biomedical research customers in North America, Europe, and Asia, documenting the breadth of reference laboratory applications across companion animal oncology and biomedical research.

Consultant POV

The Veterinary Reference Lab market’s 6.6% CAGR through 2035 from USD 5.2 billion in 2025 is structurally anchored in the most durable growth drivers in the life sciences sector — pet humanisation, food security investment, and One Health policy. Zoetis’s USD 9.5 billion 2025 revenue, 12 blockbuster-potential pipeline candidates, Elanco’s 90-plus country footprint, and IDEXX’s diagnostic innovation confirm that the IDEXX Cancer Dx Panel creating companion animal oncology screening as a mainstream annual wellness visit service will compound market growth above baseline diagnostic volume growth — with the mast cell tumour and international expansion roadmap sustaining new test category revenue through 2035.

Request Sample
Speak with an Analyst
Download TOC

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

More Press Releases

Speak with an Analyst

    Download TOC

      Request a Sample Report